Cite
HARVARD Citation
Gautier-Veyret, E. et al. (2018). Cysteinyl-leukotriene pathway as a new therapeutic target for the treatment of atherosclerosis related to obstructive sleep apnea syndrome. Pharmacological research. pp. 311-319. [Online].